Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Aoki
K. Aoki
Mitsubishi Tanabe Pharma
Hepatitis C virus
Virology
Telaprevir
Adverse effect
Hepacivirus
2
Papers
38
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.
2013
Journal of Viral Hepatitis
Joji Toyota
Itaru Ozeki
Yoshiyasu Karino
Yasuhiro Asahina
Namiki Izumi
Shoichi Takahashi
Yoshiiku Kawakami
Kazuaki Chayama
Naohiro Kamiya
K. Aoki
Ichimaro Yamada
Yuichiro Suzuki
Fumitaka Suzuki
Hiromitsu Kumada
Show All
Source
Cite
Save
Citations (12)
Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection.
2012
Journal of Viral Hepatitis
Ichimaro Yamada
Fumitaka Suzuki
Naohiro Kamiya
K. Aoki
Y. Sakurai
M. Kano
H. Matsui
H. Kumada
Show All
Source
Cite
Save
Citations (26)
1